Chalcogen Attached Indirectly To The Morpholine Ring By Acyclic Nonionic Bonding Patents (Class 514/238.8)
  • Patent number: 6184222
    Abstract: Norepinephrine reuptake inhibitors are used to treat conduct disorder.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: February 6, 2001
    Assignee: Eli Lilly and Company
    Inventor: John Harrison Heiligenstein
  • Patent number: 6177067
    Abstract: Disclosed is a hair revitalizing tonic composition containing a dimethylpropanediol derivative of the formula: wherein R1 and R2 are each independently a C1-30 hydrocarbon group which may be substituted, or a five- or six-membered heterocyclic group which contains 1 to 4 heteroatoms selected from oxygen, sulfur and nitrogen atoms and which may be substituted, R3 is hydrogen atom, an alkyl group which may be substituted, an acyl group, an alkoxycarbonyl group, a phenoxycarbonyl group, or a carbamoyl group which may be substituted, and a and b are each 0 or 1, as well as a method for effecting hair growth promotion, hair growth stimulation, or hair loss prevention in mammals by using such a hair revitalizing tonic composition. Also disclosed is the use of a compound of formula (I) in the preparation of a hair revitalizing tonic composition. Thus, this invention can provide an excellent means of hair revitalization or hair loss prevention in mammals.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: January 23, 2001
    Assignees: Shiseido Company, Ltd., Takeda Chemical Industries, Ltd.
    Inventors: Tsunao Magara, Yoshiharu Tsuji, Masahiro Tajima, Koji Kobayashi, Hirotada Fukunishi, Masazumi Watanabe